Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells

PURPOSE: To determine the ocular anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist (SEGRA) in primary human conjunctival fibroblasts and epithelial cells. METHODS: Two primary human conjunctival cell types, human conjunctival epithelial cells (HConEpiC) and human...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavet, Megan E., Volhejn, Stepan, Harrington, Karen L., Zhang, Jin-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716413/
https://www.ncbi.nlm.nih.gov/pubmed/23878502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716413/
https://www.ncbi.nlm.nih.gov/pubmed/23878502

Ejemplares similares